Table 4

Comparison of previously identified VTE risk alleles between the discovery cohort and populations of EA

Discovery cohortPrevious studies
ChrSNPAlleleAFOR (95% CI)P*AFORPReference
rs6025 (F50.0 NA NA 0.06 2.56 1.40 × 10−12 11 
11 rs1799963 (F20.0 NA NA 0.02 1.69 3.00 × 10−2 11 
rs687621 (ABO0.43 1.55 (1.2-2.0) 0.002 0.43 1.84 6.69 × 10−22 10 
rs505922 (ABO0.36 1.52 (1.2-2.0) 0.002 0.43 1.85 1.84 × 10−22 10 
rs657152 (ABO0.44 1.39 (1.1-1.8) 0.03 0.45 1.7 2.00 × 10−17 10 
10 rs78707713 (TSPAN150.97 NA NA 0.88 1.28 5.74 × 10−11 29 
19 rs2288904 (SLC44A20.93 0.90 (0.5-1.5) 0.75 0.79 1.19 1.07 × 10−9 29 
Discovery cohortPrevious studies
ChrSNPAlleleAFOR (95% CI)P*AFORPReference
rs6025 (F50.0 NA NA 0.06 2.56 1.40 × 10−12 11 
11 rs1799963 (F20.0 NA NA 0.02 1.69 3.00 × 10−2 11 
rs687621 (ABO0.43 1.55 (1.2-2.0) 0.002 0.43 1.84 6.69 × 10−22 10 
rs505922 (ABO0.36 1.52 (1.2-2.0) 0.002 0.43 1.85 1.84 × 10−22 10 
rs657152 (ABO0.44 1.39 (1.1-1.8) 0.03 0.45 1.7 2.00 × 10−17 10 
10 rs78707713 (TSPAN150.97 NA NA 0.88 1.28 5.74 × 10−11 29 
19 rs2288904 (SLC44A20.93 0.90 (0.5-1.5) 0.75 0.79 1.19 1.07 × 10−9 29 

AF, allele frequency; Chr, chromosome; NA, not available.

*

Age adjusted.

Allele frequency taken from 1000 Genomes–Americans of African Ancestry in SW USA (ASW).

Close Modal

or Create an Account

Close Modal
Close Modal